These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 26121320
1. Sialic acid supplementation ameliorates puromycin aminonucleoside nephrosis in rats. Pawluczyk IZ, Najafabadi MG, Brown JR, Bevington A, Topham PS. Lab Invest; 2015 Sep; 95(9):1019-28. PubMed ID: 26121320 [Abstract] [Full Text] [Related]
2. Sialic acid attenuates puromycin aminonucleoside-induced desialylation and oxidative stress in human podocytes. Pawluczyk IZ, Ghaderi Najafabadi M, Patel S, Desai P, Vashi D, Saleem MA, Topham PS. Exp Cell Res; 2014 Jan 15; 320(2):258-68. PubMed ID: 24200502 [Abstract] [Full Text] [Related]
3. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats. Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, Muragaki Y, Kawachi H, Shigematsu T. Clin Exp Nephrol; 2009 Oct 15; 13(5):438-446. PubMed ID: 19452240 [Abstract] [Full Text] [Related]
4. Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats. Kawamorita Y, Shiraishi T, Tamura Y, Kumagai T, Shibata S, Fujigaki Y, Hosoyamada M, Nakagawa T, Uchida S. Physiol Rep; 2017 Aug 15; 5(15):. PubMed ID: 28774949 [Abstract] [Full Text] [Related]
5. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury. Wang Z, Wei X, Zhang Y, Ma X, Li B, Zhang S, Du P, Zhang X, Yi F. Cell Physiol Biochem; 2009 Aug 15; 24(5-6):619-26. PubMed ID: 19910702 [Abstract] [Full Text] [Related]
6. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases. Dong N, Meng L, Xue R, Yu M, Zhao Z, Liu X. Int Urol Nephrol; 2017 Aug 15; 49(8):1489-1506. PubMed ID: 28528353 [Abstract] [Full Text] [Related]
7. Nicorandil protects podocytes via modulation of antioxidative capacity in acute puromycin aminonucleoside-induced nephrosis in rats. Yamanaka M, Tamura Y, Kuribayashi-Okuma E, Uchida S, Shibata S. Am J Physiol Renal Physiol; 2023 Feb 01; 324(2):F168-F178. PubMed ID: 36454699 [Abstract] [Full Text] [Related]
8. Alterations in the sialic acid content of the rat glomerular filter in aminonucleoside nephrosis. Quatacker J. Virchows Arch B Cell Pathol Incl Mol Pathol; 1986 Feb 01; 50(3):237-47. PubMed ID: 2870576 [Abstract] [Full Text] [Related]
9. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol. Ricardo SD, Bertram JF, Ryan GB. Exp Nephrol; 1995 Feb 01; 3(5):270-9. PubMed ID: 7583048 [Abstract] [Full Text] [Related]
10. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode. Kawakami H, Kamiie J, Yasuno K, Kobayashi R, Aihara N, Shirota K. Nephrol Dial Transplant; 2012 Apr 01; 27(4):1324-30. PubMed ID: 21862459 [Abstract] [Full Text] [Related]
11. Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Moreno-Manzano V, Mampaso F, Sepúlveda-Muñoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodríguez J, Nieto E, Orellana JM, Reyes P, Arribas I, Xu Q, Kitamura M, Lucio Cazana FJ. Br J Pharmacol; 2003 Jun 01; 139(4):823-31. PubMed ID: 12813006 [Abstract] [Full Text] [Related]
12. Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats. Suzuki A, Ito T, Imai E, Yamato M, Iwatani H, Kawachi H, Hori M. J Am Soc Nephrol; 2003 Apr 01; 14(4):981-91. PubMed ID: 12660332 [Abstract] [Full Text] [Related]
13. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats. Kim BS, Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY. Yonsei Med J; 2005 Feb 28; 46(1):141-8. PubMed ID: 15744817 [Abstract] [Full Text] [Related]
14. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling. Shibata S, Nagase M, Fujita T. J Am Soc Nephrol; 2006 Mar 28; 17(3):754-64. PubMed ID: 16452496 [Abstract] [Full Text] [Related]
15. Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase. Kinugasa S, Tojo A, Sakai T, Tsumura H, Takahashi M, Hirata Y, Fujita T. Kidney Int; 2011 Dec 28; 80(12):1328-38. PubMed ID: 21849973 [Abstract] [Full Text] [Related]
16. The relationship between glomerular function and podocyte structure of pre-proteinuria and acute nephrosis in puromycin aminonucleoside-induced rat models: a comparative electron microscopic study. Seçkin İ, Uzunalan M, Pekpak M, Köktürk S, Sönmez HA, Güngör ZB, Demirkiran ÖD, Saygi Hİ, Yaprak Saraç E. Rom J Morphol Embryol; 2017 Dec 28; 58(3):823-830. PubMed ID: 29250660 [Abstract] [Full Text] [Related]
17. Effects of celecoxib and nordihydroguaiaretic acid on puromycin aminonucleoside-induced nephrosis in the rat. Lee DW, Kwak IS, Lee SB, Song SH, Seong EY, Chung HC, Yang BY, Lee MY, Sol MY. J Korean Med Sci; 2009 Jan 28; 24 Suppl(Suppl 1):S183-8. PubMed ID: 19194550 [Abstract] [Full Text] [Related]
18. Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis. Wang L, Ellis MJ, Fields TA, Howell DN, Spurney RF. Kidney Blood Press Res; 2008 Jan 28; 31(2):111-21. PubMed ID: 18367845 [Abstract] [Full Text] [Related]
19. Angiotensin converting-enzyme inhibition restores glomerular glycosaminoglycans in rat puromycin nephrosis. Herman-Edelstein M, Chagnac A, Nevo Z, Skutelsky E, Evron Y, Hirsch Y, Ben-Dor L, Schwartz I, Schwartz D, Weinstein T. Exp Toxicol Pathol; 2016 Nov 28; 68(10):543-552. PubMed ID: 27591087 [Abstract] [Full Text] [Related]
20. Puromycin aminonucleoside increases podocyte permeability by modulating ZO-1 in an oxidative stress-dependent manner. Ha TS, Park HY, Seong SB, Ahn HY. Exp Cell Res; 2016 Jan 01; 340(1):139-49. PubMed ID: 26683996 [Abstract] [Full Text] [Related] Page: [Next] [New Search]